ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Nymox Pharmaceutical Corp (PK)

Nymox Pharmaceutical Corp (PK) (NYMXF)

0.08
0.01
(14.29%)
Closed 12 December 8:00AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 283k224k299k116k5k000
Operating Income -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.65M-8.79M
Pre Tax Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Net Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.267-0.238-0.164-0.185-0.151-0.147-0.073-0.095
EBIT -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.54M-8.79M
EBITDA -12.87M-13.23M-10.64M-13.33M-11.71M-12.49M-6.64M-8.79M

Your Recent History

Delayed Upgrade Clock